Vision
To be a trusted partner for pharmaceutical companies expanding into new markets, delivering consistent execution and responsible supply to improve patient access.
Vitaxis International Limited – Pharmaceutical Distribution and Trading
Purpose
We support sustainable access to medicines through compliant commercialization, distribution, and lifecycle execution across Europe and selected international markets.
Mission
To enable partners to commercialize and distribute medicinal products effectively, combining regulatory discipline, operational integrity, and local market expertise.
About us
VITAXIS International Limited is a pharmaceutical commercialization and distribution partner. We support responsible cross‑border supply and market execution in regulated and emerging environments.
- International operating model with market-specific execution.
- Long-term partnering approach aligned to regulatory obligations and patient safety.
- Quality- and compliance-driven distribution practices.
- Commercial, regulatory, and operational support across the product lifecycle.
- Transparent communication and reliable delivery for partners and stakeholders.
Geographic Focus
We support partners across Europe and selected international markets, adapting execution to local regulatory and supply environments.
Presence in more than 20 Eastern European countries:
Albania
Armenia
Azerbaijan
Belarus
Bosnia
Bulgaria
Croatia
Czech Republic
Estonia
Georgia
Hungary
Kazakhstan
Kirgizstan
Latvia
Lithuania
Moldova
Mongolia
Montenegro
North Macedonia
Poland
Romania
Russia
Serbia
Slovakia
Slovenia
Tajikistan
Turkmenistan
Ukraine
Uzbekistan
Corporate Value Chain
End-to-end pharmaceutical value chain support: sourcing, regulatory alignment, quality assurance, logistics coordination, and partner management — aligned with Good Distribution Practice (GDP) principles.
Development Partnership
- Research and Development
- Manufacturing
- Medical Affairs
- Global Communications
- Global Regulatory Affairs
VITAXIS International
- Global and Local Branding
- Warehousing & Distribution
- Advertising & Promotion
- Sales Force Excellence
- Local Regulatory Affairs
Differentiated portfolio
- Specialty Pharmaceuticals
- Supportive Treatment Medications
- Safety & Handling Medical Devices
Key Customers
We work with pharmaceutical manufacturers, brand owners, and healthcare supply partners seeking reliable distribution and commercial execution across diverse markets.
Hospitals
Pharmacies
CROs
Healthcare Professionals
Patients
Strategic Partners
Strategic partnerships enable secure, compliant and efficient market coverage, leveraging trusted distributors and healthcare stakeholders across our regions.
Products Pipeline
Our portfolio covers key therapeutic areas and healthcare needs, supporting sustainable supply and patient access with targeted therapies and supportive treatments.
Growth is driven by in-licensing, partnerships and own development, with a focus on high-priority gastroenterology and selective therapeutic areas.
Strategic Growth Areas:
- In-licensing & Contract Manufacturing – Expanding access to high-quality healthcare solutions.
- Partnerships – Engaging in co-marketing and co-promotion collaborations for mutual growth.
- Own Development – Advancing innovative healthcare solutions through in-house expertise.
Focus Therapeutic Areas:
- High Priority: Gastroenterology
- Selective Areas:
- Neurological complications
- Diabetes and related conditions
Ongoing Development Projects:
- Specialty Pharmaceuticals – Addressing critical healthcare needs with targeted therapies.
- Supportive Treatment Medications – Enhancing patient care and recovery.
- Safety & Handling Medical Devices – Ensuring effective and secure medical solutions.
Contact
For partnership discussions and general enquiries, please contact us using the form below. Safety reporting is available via the dedicated pharmacovigilance option within the form.
Safety Reporting (Adverse Events & Product Quality)
If your message concerns a suspected adverse event, product quality complaint, or other safety information, please include only what is necessary and do not include highly sensitive personal data (e.g., full patient name, address, ID numbers). We may need to follow up to meet regulatory reporting obligations and may share relevant information with marketing authorisation holders, partners, and competent authorities as required by law.